
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 25 years ago
Participating Facultyover 25 years ago
Introductionover 25 years ago
Statins--Differences and Similaritiesover 25 years ago
What Do the Statin Trials Tell Us?over 25 years ago
New Therapies on the Horizonover 25 years ago
A New Statin: A New Standard


